Louisiana Administrative Code › Title 51 - PUBLIC HEALTH-SANITARY CODE › Part II - The Control of Diseases › Chapter 1 - Disease Reporting Requirements › Section II-105 - Reportable Diseases and Conditions [formerly paragraph 2:003]

Current through Register Vol. 50, No. 6, June 20, 2024
A. It is hereby
				made the duty of every physician practicing medicine in the state of Louisiana
				to report to the state health officer, according to the requirements of this
				Section and utilizing the appropriate method(s) of reporting required under
				Subsection E of this Section, any case or suspected case of reportable disease
				or condition which he or she is attending, or has examined, or for which such
				physician has prescribed. The report shall be made promptly at the time the
				physician first visits, examines or prescribes for the patient, and such report
				shall state the name, age, sex, race, usual residence, place where the patient
				is to be found, the nature of the disease or condition and the date of onset,
				and the pregnancy status of the patient (if the pregnancy status is known and
				if it is clinically relevant to the disease or condition being reported).
				Reports of occupational disease/injury shall state contact information of the
				reporting person as well as the patients name, contact information, age (or
				date of birth), sex, race/ethnicity, usual residence, occupation, employer
				information, the nature of the disease or injury, and the date of diagnosis.
B. Any physician, whether
				Louisiana resident or nonresident, engaged in the practice of medicine at any
				federal installation or on any vessel, train or other common carrier, which
				enters any port, station or place in the state of Louisiana, is required to
				report as specified in Subsection A of this Section.
C. It shall be the duty of every osteopath,
				coroner, medical examiner, dentist, homeopath, infection control practitioner,
				laboratory director, medical records director, nurse, nurse midwife, nurse
				practitioner, pharmacist, physician assistant, podiatrist, poison control
				center, social worker, veterinarian, and any other health care professional to
				report a positive laboratory result or a confirmed or suspected case of any
				reportable disease or condition as required by this Section utilizing the
				appropriate method(s) of reporting required under Subsection E of this Section
				in which he or she has examined or evaluated, or for which he or she is
				attending or has knowledge. In the absence of a health care professional
				responsible for reporting as stated in the prior sentence (or a physician as
				referenced in Subsections A and B of this Section), it shall be the duty of the
				director, chief administrative officer, or other person in charge of any
				facility, program, or other entity that requires or conducts testing for
				reportable diseases or conditions, to report a positive laboratory result or a
				confirmed or suspected case of any reportable disease or condition as required
				by this Section utilizing the appropriate method(s) of reporting required under
				Subsection E of this Section.
D.
				The following diseases or conditions are hereby declared reportable with
				reporting requirements by class.
1. Class A
				Diseases or Conditions which Shall Require Reporting within 24 Hours
a. Class A diseases or conditions include
				diseases or conditions of major public health concern because of the severity
				of the disease or condition and the potential for epidemic spread. Class A
				diseases or conditions shall be reported to the Office of Public Health by
				telephone (or in another electronic format acceptable to the Office of Public
				Health) immediately upon recognition that a case, a suspected case, or a
				positive laboratory result is known. In addition, all cases of rare or exotic
				communicable diseases, unexplained death, unusual clusters of disease and all
				outbreaks shall be reported. Any class A disease or condition, rare or exotic
				communicable disease, unexplained death, or unusual cluster of disease and any
				disease outbreak, shall be reported to the Office of Public Health as soon as
				possible but no later than 24 hours from recognition that a case, a suspected
				case, a positive laboratory result, an unexplained death, an unusual cluster of
				disease, or a disease outbreak is known. The following diseases or conditions
				shall be classified as class A for reporting requirements:
i.
Acinetobacter
spp.,
				carbapenem-resistant;
ii. acute
				flaccid paralysis, including acute flaccid myeltis;
iii. amoeba (free living) infection
				(including
Acanthamoeba
,
Naegleria
,
Balamuthia
and others;
iv. anthrax;
v. avian or novel strain influenza A (initial
				detection);
vi. botulism;
vii. brucellosis;
viii. Candida auris, as well as common
				misidentifications of C. auris (e.g., C. haemulonii, C. duobushaemulonii, C.
				famata, C. sake, C. lusitaniae, C. parapsilosis, C. catenulata, C.
				guilliermondii, and Rhodotorula glutinis);
ix. cholera;
x. Clostridium perfringens food-borne
				illness;
xi. Coronavirus Disease
				2019 (COVID-19)/Infections with SARS-CoV-2;
xii. diphtheria;
xiii. Enterobacteriacea,
				carbenum-resistant;
xiv. fish or
				shellfish poisoning (domoic acid poisoning, neurotoxic shellfish poisoning,
				ciguatera, paralytic shellfish poisoning, scombroid);
xv. food-borne illness;
xvi. glanders (Burkholderia
				mallei);
xvii.
Haemophilus
				influenzae
(invasive infection);
xviii. influenza-associated
				mortality;
xix. measles (rubeola,
				imported or indigenous);
xx.
				melioidosis (Burkholderia pseudomallei);
xxi.
Neisseria meningitidis
(invasive infection); xxii. outbreaks of any infectious diseases;
xxiii. pertussis; xxiv. plague
				(
Yersinia pestis
);
xxv. poliomyelitis (paralytic and
				non-paralytic);
xxvi.
Pseudomonas aeruginosa
, carbapenem-resistant;
xxvii. Q fever (
Coxiella
				burnettii
);
xxviii. rabies
				(animal and human);
xxiv. ricin
				poisoning;
xxx. rubella (congenital
				syndrome);
xxxi. rubella (German
				measles);
xxxii. SARS (SARS-CoV-1
				infection);
xxxiii.
				Staphylococcu
s aureus
, vancomycin intermediate or resistant
				(VISA.VRSA);
xxxiv. staphylococcal
				enterotoxin B (SEB) pulmonary poisoning;
xxxv. smallpox;
xxxvi. tularemia (Francisella
				tularensis);
xxxvii. viral
				hemorrhagic fever (Ebola, Lassa, Marburg, Crimean Congo, etc.); and
xxxviii. yellow fever.